Pulmonary fibrosis after pegylated liposomal Doxorubicin in a patient with uterine papillary serous carcinoma.
Obstetrics, Gynecology and Womens Health, Division of Gynecologic Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY 10467, USA. nevadunskynicole@yahoo.com
Nicole S
NS
Nevadunsky
Chinyere
C
Mbagwu
Nina
N
Mizrahi
Elizabeth
E
Burton
Gary L
GL
Goldberg
D018283:Cystadenocarcinoma, Papillary / Q000188:drug therapy*; D018284:Cystadenocarcinoma, Serous / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000175:diagnosis; D014594:Uterine Neoplasms / Q000188:drug therapy*
C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin